New bladder cancer treatment trial offers hope when standard therapy fails
NCT ID NCT06388720
Summary
This study is testing whether washing the bladder with two cancer drugs, one after the other, can help control high-risk bladder cancer in patients whose cancer did not respond to the standard BCG treatment. The trial aims to see if this approach can prevent the cancer from coming back and delay or avoid the need for bladder removal surgery. Researchers will monitor 82 patients to measure how long they stay cancer-free and assess the safety of the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Center
RECRUITINGGoyang-si, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.